Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: FEVER; Information has been received from the Regulatory Authority on 20-SEP-2019, regarding a female patient of 11 age (units not provided). The patient''s pertinent past medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not provided. On an unspecified date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown), or hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (manufacturer unknown), the dose was reported as 342 milligram as prophylaxis. (strength, frequency, route, anatomical location of administration, lot number and expiration date were not provided). On an unspecified date, the patient experienced fever. On an unspecified date, the patient died from an unknown cause. It was unknown if an autopsy was performed. The causality assessment between HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (manufacturer unknown) and Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (manufacturer unknown) and fever was not provided by the Health Authority.; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166